Inventor · disambiguated record
Yasuki Niwa
Also filed as: Niwa yasuki
6 granted patents·4 pending applications·10 citations·filing 2012–2025
73Inventor score
Top patents by PatentIndex Score
10 records- 0189US11890288B2Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Feb 6, 2024·2 cites·11 claims
- 0281US8987445B2Sulfonamide compounds having TRPM8 antagonistic activityTSUZUKI YASUYUKI·Filed 2012·Granted Mar 24, 2015·8 cites·25 claims
- 0372US2024390387A1Sulfonamide or sulfinamide compound having effect of inducing brd4 protein degradation and pharmaceutical use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2024·Application pending·0 cites
- 0468US2023348363A1Compounds and their useASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0567US11667602B2Compounds and their useASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·0 cites·6 claims
- 0660US12102641B2Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2021·Granted Oct 1, 2024·0 cites·19 claims
- 0750US2025388593A1Cereblon e3 ligase binding compound, pharmaceutical composition containing same, and production method thereforMITSUBISHI TANABE PHARMA CORP·Filed 2025·Application pending·0 cites
- 0848US2023312542A1Hydroxypyrrolidine derivative and medicinal application thereofMITSUBISHI TANABE PHARMA CORP·Filed 2021·Application pending·0 cites
- 0940US11542273B2Amide compound having bet proteolysis-inducing action and medicinal application thereofMITSUBISHI TANABE PHARMA CORP·Filed 2019·Granted Jan 3, 2023·0 cites·25 claims
- 1038US9540360B2Sulfonamide compounds having TRPM8 antagonistic activityTSUZUKI YASUYUKI·Filed 2015·Granted Jan 10, 2017·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Yasuki Niwa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →